Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
about
SUMOylation-Mediated Regulation of Cell Cycle Progression and CancerThe Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.A Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle.Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3.Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosisInhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasCompositional Control of Phase-Separated Cellular Bodies.Targeting nuclear thymidylate biosynthesis.SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase.Ubc9 Binds to ADAP and Is Required for Rap1 Membrane Recruitment, Rac1 Activation, and Integrin-Mediated T Cell Adhesion.Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.SUMO targets the APC/C to regulate transition from metaphase to anaphase.The post-translational modification, SUMOylation, and cancer (Review).Regulation of miR-34b/c-targeted gene expression program by SUMOylation.
P2860
Q26776081-74B42791-333C-41BF-B627-6FD27160DE48Q35823090-C5C44EB0-7991-41E1-8787-1ED99ADA6C52Q36333305-FB8ACBDE-28A6-474C-8E78-EAE7E5922B31Q36772148-D0C70FC2-1576-476D-A7CF-2DDC5E7511F9Q37153640-AE3856AC-4906-49CC-AD5B-AC4EB53F4C73Q37555371-3F4359DB-30AE-4193-8C9A-3A1DCBF6CF80Q38727673-D2B2CC00-8012-4605-A9E4-D2B20C28DD04Q38760132-26A85960-896E-409C-AF76-40235112988CQ39017134-5C664F85-B63D-410A-A9DB-BB99A1721D19Q42408048-E70065BA-318A-4E56-86B6-DAC2CE642345Q47414975-DD4D2790-57BE-479D-9CED-FFEF9F50EE19Q47823549-086EF7E1-7BC0-43A8-90BE-A8420F496414Q49569565-E231ADBA-A924-49B2-B78A-0589E2BDC30CQ51159598-8C7D83EB-FCA4-4AF8-9943-615C5599F5FCQ52352276-6EFA6404-731D-44CD-B822-1619935310DDQ52730181-EBBAC5B7-6CA6-4387-A485-779894FE1C6EQ54976422-2291EAEB-BB11-4B3A-8E93-2D43BDB8FA10
P2860
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterization of the loss o ...... cells and tumor proliferation.
@ast
Characterization of the loss o ...... cells and tumor proliferation.
@en
type
label
Characterization of the loss o ...... cells and tumor proliferation.
@ast
Characterization of the loss o ...... cells and tumor proliferation.
@en
prefLabel
Characterization of the loss o ...... cells and tumor proliferation.
@ast
Characterization of the loss o ...... cells and tumor proliferation.
@en
P2093
P2860
P1433
P1476
Characterization of the loss o ...... cells and tumor proliferation.
@en
P2093
James E Brownell
Jessica Riceberg
John Newcomb
Larry Dick
Neil Bence
Pooja Shah
Sai M Pulukuri
Steve Grossman
Vaishali Shinde
Xingyue He
P2860
P304
P356
10.1371/JOURNAL.PONE.0123882
P407
P577
2015-04-10T00:00:00Z